Method for determination of sensitivity to anti-cancer agent

作者: Yusuke Tanigawara , Akito Nishimuta , Yasuko Yamayoshi , Mitsuhiro Watanabe , Shinji Sugimoto

DOI:

关键词:

摘要: Provided are a marker for determining sensitivity to an anticancer agent capable of distinguishing therapeutic response individual patient and novel means cancer therapy using the marker. The contains substance in metabolic pathway which L-phenylalanine and/or N,N-dimethyl glycine are/is involved.

参考文章(77)
Kathleen M. Giacomini, Anna Lapuk, Joe W. Gray, Shuzhong Zhang, Use of organic cation transporters for cancer diagnosis and therapy ,(2007)
Tsao-Wei D, Stoehlmacher J, Groshen S, Lenz Hj, Iobal S, Ghaderi, Park D, A polymorphism of the XRCC1 gene predicts for response to platinum based treatment in advanced colorectal cancer. Anticancer Research. ,vol. 21, pp. 3075- 3079 ,(2001)
Yusuke Tanigawara, Akito Nishimuta, Shinji Sugimoto, Yoshiaki Igarashi, Tetsuya Suzuki, Anticancer agent sensitivity-determining marker ,(2010)
Chris Beecher, Alvin Berger, Kay A. Lawton, Matthew W. Mitchell, Biomarkers for prostate cancer and methods using the same ,(2007)
Hiroshi Kuga, Yasuhide Hirota, Yasuyoshi Kawato, Keiki Sato, Masashi Aonuma, Intracellular Roles of SN-38, a Metabolite of the Camptothecin Derivative CPT-11, in the Antitumor Effect of CPT-11 Cancer Research. ,vol. 51, pp. 4187- 4191 ,(1991)
Yusuke Tanigawara, Akito Nishimuta, Sayo Suzuki, Shinji Sugimoto, Hidehiro Irie, Tetsuya Suzuki, Method for determining sensitivity to an anticancer agent ,(2010)